Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028 Donia, M.; Jespersen, H.; Jalving, M.; Lee, R.; Eriksson, H.; Hoeller, C.; Hernberg, M.; Gavrilova, I.; Kandolf, L.; Liszkay, G.; Helgadottir, H.; Zhukavets, A.; Pianova, D.; Marquez-Rodas, I.; Neyns, B.; Westgeest, H.; Pourmir, I.; Sobczuk, P.; Ellebaek, E.; Amaral, T. Share Save
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma Handel, Eleanor E.; Mckeown, Janet; Wei, Joe; Kankaria, Roma A.; Burnette, Hannah; Johnson, Douglas B.; Lawless, Aleigha; Czapla, Juliane; Sullivan, Ryan J.; Albrecht, Lea Jessica; Zimmer, Lisa; Mangana, Joanna; Dummer, Reinhard; Kessels, Jolien I.; Neyns, Bart; Allayous, Clara; Lebbe, Celeste; Boatwright, Christina; Mehnert, Janice M.; Ottaviano, Margaret; Ascierto, Paolo A.; Czarnecka, Anna M.; Rutkowski, Piotr; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Carlino, Matteo S. Share Save
FIRST IN HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA (GBM): FIRST RESULTS FROM THE DOSE ESCALATION PHASE Tabatabai, Ghazaleh; Freres, Pierre; Glas, Martin; Hau, Peter; von Baumgarten, Louisa; van den Bent, Martin; Burger, Michael C.; Seidel, Clemens; Herrlinger, Ulrich; Mildenberger, Iris; Neyns, Bart; Schafer, Henning; Wick, Antje; Falk, Martin; de Chama, Laura Leticia Freitas; Kelemen, Peter; Schwenke, Frauke; Koch, Sven D.; Roche, Paula Romer; Gnad-Vogt, Ulrike Share Save
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy Woodford, Rachel; McKeown, Janet; Hoeijmakers, Lotte L.; Mangana, Johanna; Dimitriou, Florentia; Allayous, Clara; Zaman, Farzana; Aya, Francisco; Marsiglio, John; Goodman, Rachel; Rayson, Victoria; Placzke, Joanna; Kessels, Jolien; Ramalyte, Egle; Haque, Waqas; Wilson, Isabella; Trojaniello, Claudia; Benannoune, Naima; Roberts-Thomson, Rachel; Robert, Caroline; Blank, Christian U.; Dummer, Reinhard; Lebbe, Celeste; Haydon, Andrew; Arance, Ana; Hu-Lieskovan, Siwen; Johnson, Douglas B.; Mcarthur, Grant A.; Rutkowski, Piotr; Neyns, Bart; Sullivan, Ryan J.; Weber, Jeffrey; Carlino, Matteo S.; Ascierto, Paolo A.; Lo, Serigne; Long, Georgina, V; Menzies, Alexander M. Share Save
Share Save
A REPEATED INTRACRANIAL ADMINISTRATION OF ANTI-PD-1 ALONE OR IN COMBINATION WITH ANTI-CTLA-4 IMMUNE CHECKPOINT-BLOCKING MONOCLONAL ANTIBODIES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA Lescrauwaet, L.; Dirven, I; Del'haye, J.; Geens, W.; Geeraerts, X.; Stevens, L.; Brock, S.; Kockx, M.; Seynaeve, L.; Everaert, H.; Vanbinst, A.; Tuyaerts, S.; Neyns, B.; Duerinck, J. Share Save
A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF AUTOLOGOUS CD1C(BDCA-1)+ /CD141(BDCA-3)+ MYELOID DENDRITIC CELLS IN COMBINATION WITH IPILIMUMAB AND NIVOLUMAB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA Duerinck, J.; Lescrauwaet, L.; Dirven, I; Del'haye, J.; Cammaert, M.; Geens, W.; Geeraerts, X.; Stevens, L.; Brock, S.; Kockx, M.; Everaert, H.; Vanbinst, A.; Tuyaerts, S.; Neyns, B. Share Save
Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma Duerinck, Johnny; Lescrauwaet, Louise; Dirven, Iris; Del'haye, Jacomi; Stevens, Latoya; Geeraerts, Xenia; Vaeyens, Freya; Geens, Wietse; Brock, Stefanie; Vanbinst, Anne-Marie; Everaert, Hendrik; Caljon, Ben; Bruneau, Michael; Lebrun, Laetitia; Salmon, Isabelle; Kockx, Marc; Tuyaerts, Sandra; Neyns, Bart Share Save
Share Save
First in human study of the mRNA-based cancer vaccine CVGBM in patients (pts) with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma (GBM): First results from the dose escalation phase Tabatabai, G.; Freres, P.; Glas, M.; Hau, P.; von Baumgarten, L.; van den Bent, M. J.; Burger, M. C.; Seidel, C.; Herrlinger, U.; Mildenberger, I.; Neyns, B.; Schafer, H.; Wick, A.; Falk, M. H.; Chama, L. L. de Freitas; Kelemen, P. G.; Schwenke, F.; Koch, S. D.; Roche, P. Romer; Gnad-Vogt, U. S. Share Save
Share Save
A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG) Neyns, B.; Dirven, I.; Lescrauwaet, L.; Cammaert, M.; Geens, W.; Geeraerts, X.; Stevens, L.; Brock, S.; Kockx, M.; Everaert, H.; Van Binst, A-M.; Tuyaerts, S.; Duerinck, J. Share Save
Intratumoral (IT) administration of autologous CD1c(BDCA-1)+/CD141(BDCA-3)+myeloid dendritic cells (myDC) with the immunologic adjuvant AS01B plus ipilimumab (IPI) and IV nivolumab (NIVO) in patients with refractory advanced melanoma: A phase Ib clinical trial Vounckx, M.; Dirven, I.; Kessels, J. I.; Stevens, L.; Geeraerts, X.; Boisson, A.; Van Riet, I.; Forsyth, R.; Willard-Gallo, K.; Tuyaerts, S.; Neyns, B. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
